Grace Therapeutics, Inc. (GRCE)
3.34
+0.10
(+3.09%)
USD |
NASDAQ |
Dec 16, 16:00
3.36
+0.02
(+0.60%)
Pre-Market: 20:00
Grace Therapeutics EPS Diluted (Quarterly): -0.0589 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.938M |
| Total Expenses (Quarterly) | 0.938M |
| Enterprise Value | 34.82M |
| Earnings Yield | -17.51% |
| Normalized Earnings Yield | -20.63 |